Results 221 to 230 of about 594,928 (357)

Virome diversity in small mammals from south China: Insights into virus evolution, transmission, and ecology. [PDF]

Virol Sin
Shi Y, Fang L, Li C, Li P, Liu J, Chen Y, Zhao Y, Li Z, Liu S, Ding Y, Zhou X, Jiang D, Shen J, Zhang Z, Lyu J, Pu R, Tan X, Yin J, Shi W, Cao G.   +19 more
europepmc   +1 more source

Inference of Nipah virus evolution, 1999-2015. [PDF]

Virus Evol, 2021
Whitmer SLM, Lo MK, Sazzad HMS, Zufan S, Gurley ES, Sultana S, Amman B, Ladner JT, Rahman MZ, Doan S, Satter SM, Flora MS, Montgomery JM, Nichol ST, Spiropoulou CF, Klena JD.   +15 more
europepmc   +1 more source

Simian Immunodeficiency Virus (SIV) from Sun-Tailed Monkeys (Cercopithecus solatus): Evidence for Host-Dependent Evolution of SIV within theC. lhoestiSuperspecies

, 1999
Brigitte Beer, Elizabeth Bailes, Robert Goeken, George Dapolito, Cheik Coulibaly, Stephen Norley, Reinhard Kurth, Jean‐Pierre Gautier, Annie Gautier‐Hion, Dominique Vallet, Paul M. Sharp, Vanessa M. Hirsch   +11 more
openalex   +1 more source

Evolution in the Hypervariable Region of Hepatitis C Virus in Infants after Vertical Transmission [PDF]

, 2000
Jun Murakami, Manabu Okamoto, Hironori Miyata, Ikuo Nagata, Kazuo Shiraki, Shigeo Hino   +5 more
openalex   +1 more source

A Twist in the Diagnosis: Chronic Arthropathy Without Inflammation

Arthritis Care &Research, EarlyView.
María Á. Puche‐Larrubia, Inmaculada C. Aranda‐Valera, Alejandro Escudero‐Contreras, Rosa Roldán‐Molina   +3 more
wiley   +1 more source

Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy

Advanced Functional Materials, EarlyView.
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang, Huiying Li, Shuodan Huang, Linxuan Zhang, Yan Gao, Ruoran Wang, Xiaoyu Wang, Hélder A. Santos, Zhenyu Yin, Bing Xia   +9 more
wiley   +1 more source

Generative prediction of real-world prevalent SARS-CoV-2 mutation with in silico virus evolution. [PDF]

Brief Bioinform
Liu X, Nie Z, Si H, Shen X, Liu Y, Huang X, Dong T, Xu F, Ren Z, Zhou P, Chen J.   +10 more
europepmc   +1 more source

Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip. [PDF]

Microbiol Spectr, 2021
Si L, Bai H, Oh CY, Jin L, Prantil-Baun R, Ingber DE.   +5 more
europepmc   +1 more source

Cholesterol in mRNA‐Lipid Nanoparticles can be Replaced with the Synthetic Mycobacterial Monomycoloyl Glycerol Analogue MMG‐1

Advanced Functional Materials, EarlyView.
This study demonstrates that cholesterol in messenger RNA‐lipid nanoparticles (mRNA‐LNPs) can be completely replaced with an immunopotentiating lipid, i.e., a synthetic analogue of the C‐type lectin receptor agonist monomycoloyl glycerol (MMG‐1), without compromising physicochemical properties, in vivo transfection efficiency, and immunogenicity of the
Abhijeet G. Lokras, Saahil S. Baghel, Rune F. Jensen, Aneesh Thakur, Henrik Franzyk, Oskar Thofte, Marco Herrera‐Barrera, Madeleine Landry, Melike Ongun, Ahmad Tami, Marlene P. Thanthrige, Eva Callens, Corinne Beinat, Thomas Rades, Søren R. Paludan, Kristian Riesbeck, Ida Rosenkrands, Dennis Christensen, Gabriel K. Pedersen, Camilla Foged   +19 more
wiley   +1 more source

Quantitatively analyzing the relationship between non-pharmaceutical interventions and the direction of virus evolution using a dynamic model. [PDF]

Front Public Health
Guo Z, Chen Y, Liu H, Xiao G, Yu D, Zhang Z, Yang Y, Yin Z, Zhang H.   +8 more
europepmc   +1 more source